Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
Sponsor: InventisBio Co., Ltd
Summary
A Study looking at the safety and efficacy of D-2570 in Participants with Plaque Psoriasis
Official title: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Study to Evaluate the Efficacy and Safety of D-2570 in Participants With Moderate to Severe Plaque Psoriasis
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
75
Start Date
2026-06-03
Completion Date
2027-12
Last Updated
2026-07-09
Healthy Volunteers
No
Conditions
Interventions
D-2570 Tablet
Active Treatment
Placebo Tablets
Identical Tablet
Locations (20)
Study Center
Birmingham, Alabama, United States
Study Center
Phoenix, Arizona, United States
Study Center
Chula Vista, California, United States
Study Center
Fountain Valley, California, United States
Study Center
Fremont, California, United States
Study Center
Los Angeles, California, United States
Study Center
Los Angeles, California, United States
Study Center
San Diego, California, United States
Study Center
Fort Lauderdale, Florida, United States
Study Center
Miramar, Florida, United States
Study Center
Ocala, Florida, United States
Study Center
Tampa, Florida, United States
Study Center
Sandy Springs, Georgia, United States
Study Center
Savannah, Georgia, United States
Study Center
Idaho Falls, Idaho, United States
Study Center
Clarksville, Indiana, United States
Study Center
Louisville, Kentucky, United States
Study Center
Mayfield Heights, Ohio, United States
Study Center
Philadelphia, Pennsylvania, United States
Study Center
San Antonio, Texas, United States